View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

HIV/AIDS News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 12, 2011
1 min read
Save

NIH to fund new grants for HIV research

The National Institute of Allergy and Infectious Diseases of the NIH announced it will fund 5-year grants to three HIV research teams for a total of $14 million within the first year.

SPONSORED CONTENT
July 07, 2011
2 min read
Save

Caution urged for expectant mothers on ritonavir-boosting regimen

Caution urged for expectant mothers on ritonavir-boosting regimen

Mothers who have HIV and were treated before and after birth with lopinavir-ritonavir were more likely to have infants with adrenal dysfunction compared with a zidovudine-based regimen, according to a preliminary report published online this week.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
June 15, 2011
1 min read
Save

HAART effective in reducing pediatric mortality, even in resource-limited settings

Initiating highly active antiretroviral therapy early markedly improved the survival of children infected with HIV, even in an area with limited resources, according to a study published online this week.

SPONSORED CONTENT
May 18, 2011
1 min read
Save

NIAID director comments on HIV Vaccine Awareness Day

A safe and effective HIV vaccine may be possible, according to a statement from Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the NIH.

SPONSORED CONTENT
May 17, 2011
1 min read
Save

Analysis of HIV antibodies provides further insight into immune escape, potential vaccine

Antibody-dependent cellular cytotoxicity antibodies applied pressure on the HIV virus but failed to recognize the concurrent HIV sequence in a series of epitopes, according to study results.

SPONSORED CONTENT
May 13, 2011
1 min read
Save

FDA tentatively approves abacavir combination tablet for children

The FDA has granted tentative approval for a fixed-dose combination tablet containing 60 mg abacavir sulfate and 30 mg lamivudine for the treatment of HIV in children aged 3 months and older.

SPONSORED CONTENT
April 27, 2011
1 min read
Save

Children appear more likely to fail triple-drug ART regimen

As much as 12% of children develop triple-class virologic failure 5 years after starting an antiretroviral therapy regimen, according to data published online.

SPONSORED CONTENT
April 26, 2011
1 min read
Save

Children with HIV experienced good long-term outcomes on multiple treatment regimens

Switching treatment regimens at different viral load points yielded similar outcomes in a cohort of children with HIV, according to study results.

SPONSORED CONTENT
April 06, 2011
1 min read
Save

Access to health care difficult for those with HIV

As the HIV health care work force grows closer to retirement age and fewer medical students enter this particular facet of infectious disease medicine, access to care may become more difficult, according to a recent Institute of Medicine report.

SPONSORED CONTENT
March 10, 2011
1 min read
Save

HHS encourages women and girls to take action against HIV/AIDS

Today, National Women and Girls HIV/AIDS Awareness Day observes females nationwide, and encourages people to take action in the fight against HIV/AIDS.

View more